Zevra Therapeutics, Inc.
ZVRA • NASDAQ
Zevra Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Neil F. McFarlane, with a market cap of $570.1M.
Market Cap$570.1M
Employees69.0
CEONeil F. McFarlane
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Zevra Therapeutics, Inc. FAQ
Common questions about Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $31.7M.
Zevra Therapeutics, Inc. has approximately 69 employees.